Results 31 to 40 of about 377,706 (260)

Hypertension in malignancy-an underappreciated problem [PDF]

open access: yesOncotarget, 2018
Hypertension is one of the most common comorbidities in cancer patients with malignancy, in particular, in the elderly. On the other hand, hypertension is a long-term consequence of antineoplastic treatment, including both chemotherapy and targeted agents.
Jolanta Małyszko   +4 more
openaire   +2 more sources

Clinico-Histological Features of Thrombotic Microangiopathy in Renal Biopsies: A Retrospective Study

open access: yesTürk Patoloji Dergisi, 2022
Objective: Thrombotic microangiopathy (TMA) is often first detected on a renal biopsy performed for renal manifestations. Apart from hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura, there are various secondary conditions ...
Niraimathi MANICKAM   +4 more
doaj   +1 more source

The effects of acute administration of losartan, angiotensin II type-1 receptor antagonist, on hemodynamics and oxidative stress parameters in malignant hypertensive rats [PDF]

open access: yesVeterinarski Glasnik, 2015
Malignant hypertension is a severe form of hypertension which pathogenesis is not fully elucidated. The aim of our study was to investigate the role of Angiotensin II on hemodynamic and oxidative stress parameters in model of malignant ...
Bogunović Natalija   +7 more
doaj   +1 more source

Bilateral disk edema with retinitis pigmentosa: Diagnostic dilemma

open access: yesIndian Journal of Ophthalmology. Case Reports, 2023
Bilateral disk edema in a case of retinitis pigmentosa can cause diagnostic confusion and delay in treatment. Existing literature shows few such cases where inflammatory pathology is postulated.
Priyadarshini Mishra   +3 more
doaj   +1 more source

Clinical characteristics and genetic profile of complement system in renal thrombotic microangiopathy in patients with severe forms of arterial hypertension

open access: yesТерапевтический архив
Background. The spectrum of diseases characterized by the development of renal thrombotic microangiopathy (TMA) encompasses the malignant hypertension (MHT).
Mariam I. Akaeva   +7 more
doaj   +1 more source

A Case of Malignant Hypertension-Induced Thrombotic Microangiopathy with Gradually Improved Renal Function Using Appropriate Antihypertensives

open access: yesTurkish Journal of Nephrology, 2021
Malignant hypertension sometimes causes microangiopathic hemolytic anemia (MAHA) and thrombotic microangiopathy (TMA). TMA results in the obstruction of arterioles and capillaries due to microvascular thrombosis. The pathological diagnosis of TMA is done
Feyza Bora   +3 more
doaj   +1 more source

Bilateral and metastatic pheochromocytoma in a 11-year-old child: A case report

open access: yesJournal of Pediatric Surgery Case Reports, 2023
Introduction: Pheochromocytomas are rare neuroendocrine tumors. Bilateral and metastatic pheochromocytoma in children is even rarer. We report a case of a 11-year-old girl presenting with malignant hypertension related to a bilateral and metastatic ...
Takwa Mili   +7 more
doaj   +1 more source

A case of malignant hypertension

open access: yesThe British Journal of Radiology, 1992
A 44-year-old woman presented with a 3 day history of central visual field impairment in the left eye, which had not changed since onset. The only past medical history of note was that during both pregnancies she had been hypertensive, for which she had required hospital admission.
P H, Williams, A P, Hemingway
openaire   +2 more sources

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo   +5 more
wiley   +1 more source

The Pathogenesis of Malignant Hypertension [PDF]

open access: yesCirculation, 1952
Whether hypertension follows the benign or the malignant course depends chiefly on the severity of the hypertension. Malignant hypertension may develop in hypertension due to any cause, provided it is sufficiently severe. The evidence for this hypothesis is as follows: 1.
openaire   +2 more sources

Home - About - Disclaimer - Privacy